Demonstrating the safety and effectiveness of an anti-seizure medication with real-world data
A pharmaceutical manufacturer wanted a better understanding of its anti-seizure medication's safety profile and effectiveness, to identify suitable patients and compare it against competing treatments. Using real-world data via HealthVerity's platform, and synchronizing it with the company's patient support program data, the manufacturer conducted six effectiveness and comparative studies. The landing page describes this multi-study approach but does not disclose specific efficacy numbers or outcomes.
The customer is anonymised in HealthVerity’s own case study — not withheld by us.
HealthVerity is a real-world-data marketplace aggregating claims, EHR and lab data from 75+ sources via a proprietary patient-matching layer.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by HealthVerity on its own site — read the original case study on info.healthverity.com ↗
Related use cases
- 01Symphony Health and dentsu health partner to efficiently reach rare disease patients
- 02Differentiating TYK2 inhibitors with real-world evidence in psoriasis
- 03How HealthVerity Audiences delivered 26.9x targeting precision for a rare kidney disease campaign
- 04Reducing targeting noise by supplementing claims with oncology labs: Metastatic breast cancer case study
- 05Accurately targeting chronic liver disease patients for specialty therapy
- 06Accurately reaching patients with rare hematologic disease